𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results

✍ Scribed by F. Stocchi; L. Vacca; M. F. De Pandis; L. Barbato; M. Valente; S. Ruggieri

Publisher
Springer Milan
Year
2001
Tongue
English
Weight
41 KB
Volume
22
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of long-term continuous subcuta
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
✍ Pedro J. García Ruiz; Ángel Sesar Ignacio; Begoña Ares Pensado; Alfonso Castro G 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## Abstract Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long‐term treated with CSAI. We reviewed data from 82 patie

Motor fluctuations during continuous lev
Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease
✍ John G. Nutt; Julie H. Carter; Eric S. Lea; William R. Woodward 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 975 KB

## Abstract The cause of motor fluctuations occurring during constant‐rate levodopa infusions is unknown. We examined whether known pharmacokinetic factors could explain the fluctuations and looked for clues to pharmacodynamic causes. Eleven subjects with stage III–V Parkinson's disease (PD) and a

Comparative cognitive effects of bilater
Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
✍ Montse Alegret; Francesc Valldeoriola; MaJosé Martí; Manuela Pilleri; Carme Junq 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract Bilateral subthalamic deep brain stimulation (STN‐DBS) and continuous subcutaneous infusion of apomorphine (APM‐csi) can provide a comparable improvement on motor function in patients with advanced Parkinson's disease (PD), but the mechanisms by which both therapies exert their effects

Long-term results with cisapride in Park
Long-term results with cisapride in Parkinson's disease
✍ Dr. med. Wolfgang H. Jost; Klaus Schimrigk 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract In this study, we examined whether there is a longterm effect of cisapride on colonic transit in Parkinson's disease. Twenty‐five patients (11 women, 14 men; average age, 64.4 years; moderate symptoms) were studied and treated initially with cisapride, 5 mg, twice a day, and after the f

Dopaminergic responsiveness to apomorphi
Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
✍ J. Vaamonde; M. R. Luquin; Dr. J. A. Obeso 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa‐carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneou